| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |